Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection

Maghbooli, Zhila; Ali Sahraian, Mohammad; Ebrahimi, Mehdi; Pazoki, Marzieh; Kafan, Samira; Moradi Tabriz, Hedieh; Hadadi, Azar; Montazeri, Mahnaz; Nasiri, Mehrad; Shirvani, Arash; F. Holick, Michael

doi:10.1371/journal.pone.0239799

Public

Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection

Published in PLoS ONE • Sep 25, 2020

Authors:

Zhila Maghbooli

Mohammad Ali Sahraian

Mehdi Ebrahimi

Abstract

BACKGROUND: To investigate the association between serum 25-hydroxyvitamin D levels and its effect on adverse clinical outcomes, and parameters of immune function and mortality due to a SARS-CoV-2 infection. STUDY DESIGN: The hospital data of 235 patients infected with COVID-19 were analyzed. RESULT...

Subject

Medicine

Vitamin D and neurology

Confounding

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!